Yayın:
Development of a validated HPLC method for simultaneous determination of olanzapine and aripiprazole in human plasma

dc.contributor.authorATİLA KARACA, SAKİNE
dc.contributor.authorYENİCELİ, DUYGU
dc.contributor.orcid0000-0002-9440-3438
dc.contributor.orcid0000-0001-8765-4434
dc.date.accessioned2025-11-13T11:22:29Z
dc.date.issued2018-07-02
dc.identifier.doihttps://doi.org/10.12991/jrp.2018.90
dc.identifier.endpage171
dc.identifier.issn2630-6344
dc.identifier.issue1
dc.identifier.openalexW2810714029
dc.identifier.startpage162
dc.identifier.urihttps://hdl.handle.net/11421/6588
dc.identifier.urihttps://doi.org/10.12991/jrp.2018.90
dc.identifier.volume22
dc.language.isoen
dc.relation.ispartofJournal of Research in Pharmacy
dc.rightsopenAccess
dc.subjectAripiprazole
dc.subjectOlanzapine
dc.subjectHuman plasma
dc.subjectChromatography
dc.subjectChemistry
dc.subjectPlasma concentration
dc.subjectPharmacology
dc.subjectMedicine
dc.subjectSchizophrenia (object-oriented programming)
dc.subjectPsychiatry
dc.subject.sdg2
dc.titleDevelopment of a validated HPLC method for simultaneous determination of olanzapine and aripiprazole in human plasma
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5032113699
local.authorid.openalexA5072758293

Dosyalar

Koleksiyonlar